Mythbusters in Microsurgery: Evaluating Evidence and Debunking Dogma-A Practical Review: Part I

显微外科领域的流言终结者:评估证据并揭穿教条——实用回顾(第一部分)

阅读:1

Abstract

BACKGROUND: Reconstructive microsurgery has become a cornerstone in the management of complex tissue defects, yet many perioperative practices remain rooted in tradition rather than robust evidence. Persistent complications and variable protocols necessitate systematic evaluation of these dogmas to guide best practices. METHODS: We conducted a comprehensive literature review of all major databases to identify all studies addressing techniques, perioperative care, monitoring, patient selection, and recovery in reconstructive microsurgery. Relevant studies were assessed and graded using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system. When available, meta-analyses and updated systematic reviews were prioritized; individual studies within such analyses were not separately reported to avoid redundancy. RESULTS: Eight commonly held perioperative myths were critically appraised. Evidence demonstrates that judicious intraoperative vasopressor use does not increase flap compromise or loss. Perioperative nonsteroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, do not raise the risk of hematoma or thrombosis. Routine therapeutic anticoagulation or dextran use provides no benefit in flap survival and increases bleeding risk. High-dose perioperative steroids are associated with greater flap and wound complications. Extended antibiotic prophylaxis beyond 24 hours postoperatively does not reduce surgical site infections. Negative-pressure wound therapy is safe for free flaps. Most vascular compromises occur within 48-72 hours, supporting step-down monitoring thereafter. Finally, advanced age, diabetes, obesity, or immunosuppression due to solid organ transplantation or other reasons should not preclude patients from getting microsurgical reconstruction. CONCLUSIONS: Many entrenched perioperative practices in microsurgery lack contemporary evidence. Evidence-based adoption of updated protocols can minimize complications, standardize care, and improve outcomes in reconstructive microsurgery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。